Levine Cancer Institute at Atrium Health

Levine Cancer Institute at Atrium Health

This is your central portal for breaking news, the latest research and important updates from Levine Cancer Institute at Atrium Health. Bookmark this page and check back often for updates.

Cover Story

Pancreatic cancer — a changing outlook if diagnosed early

HemOnc Today, January 10, 2020
Tumor DNA sequencing to identify appropriate targeted therapies is revolutionizing treatment of a variety of cancers, and pancreatic cancer — a…
In the JournalsPerspective

Prediction model shows potential for identifying cancer survivors at risk for opioid misuse

January 3, 2020
A novel predictive model appeared to identify cancer survivors at increased risk for opioid misuse, according to study results published in Journal
Editorial

Mi oh mi-RNA and ... mi-too: New biomarkers for germ cell tumors

HemOnc Today, December 25, 2019
Derek Raghavan, MD, PhD
MicroRNAs — small noncoding RNAs that seem to be involved in epigenetic control of gene expression — have garnered increasing attention…
Meeting NewsPerspective

Co-mutations may impact response to quizartinib for relapsed/refractory acute myeloid leukemia

December 23, 2019
ORLANDO — Quizartinib significantly prolonged survival compared with salvage chemotherapy among patients with relapsed or refractory acute…
Meeting News

Daratumumab-based triplet regimen extends PFS in advanced multiple myeloma

December 15, 2019
ORLANDO — A novel triple-agent combination of carfilzomib, dexamethasone and daratumumab outperformed carfilzomib plus dexamethasone in terms…
Meeting NewsPerspective

Treatment at safety net cancer center may overcome racial disparities in DLBCL outcomes

December 8, 2019
ORLANDO — White and nonwhite patients with de novo diffuse large B-cell lymphoma treated at a safety net cancer center demonstrated similar…
Editorial

Oxygen: A ‘Nobel’ gas

HemOnc Today, November 25, 2019
Derek Raghavan, MD, PhD
Those of you who remember the tedious hours expended in learning chemistry on the pathway to a medical degree may recall the noble gases from the…
Meeting NewsPerspective

Novel blood tests could improve cancer detection

November 14, 2019
Two novel blood assays demonstrated efficacy in detecting various cancer types at different disease stages, according to results of two studies…
In the JournalsPerspective

Symptom burden a key component of disease control assessment in polycythemia vera

November 8, 2019
Patients with polycythemia vera can experience high symptom burden even if their blood counts are controlled, according to an analysis from the…
Editorial

Slow progress in advanced mesothelioma: Is the FDA winning the battle with the EPA?

HemOnc Today, October 25, 2019
Derek Raghavan, MD, PhD
Last month, I mentioned my favorite new oxymoron — “Environmental Protection Agency” — and am concerned you might have…
Meeting News

Anxiety, depression linked to pain intensity among patients with cancer

October 23, 2019
Higher levels of anxiety and depression among patients with cancer appeared to be associated with more severe disease-related pain, according to…
Point/Counter

Is social media a ‘slippery slope’ in medicine that should be avoided?

HemOnc Today, October 10, 2019
POINT Accurate and relevant medical information can help patients better engage in their care and medical decisions. It is important, however, that…

Nivolumab-ipilimumab combination benefits women with advanced cervical cancer

September 30, 2019
BARCELONA, Spain — Nivolumab in combination with ipilimumab conferred clinical benefit for women with recurrent or metastatic cervical cancer…
In the Journals

Nivolumab shows promise in recurrent or metastatic cervical, vaginal/vulvar cancers

September 25, 2019
Nivolumab showed promising efficacy among women with recurrent or metastatic cervical, vaginal or vulvar cancers, according to results from the…
Feature

Supportive care measures underused among older patients with multiple myeloma

HemOnc Today, September 25, 2019
Older adults with multiple myeloma in the United States significantly underused guideline-recommended supportive care measures, and this…
Editorial

Hey, government people, have you heard about mesothelioma?

HemOnc Today, September 25, 2019
Derek Raghavan, MD, PhD
Just when you think it cannot become worse, it does. For many decades, we have known about the hazards of asbestos, as well as its relationship to…
In the Journals

Pembrolizumab fails to improve outcomes in multiple myeloma

August 26, 2019
The addition of pembrolizumab to standard therapy failed to improve clinical outcomes for patients with untreated or relapsed/refractory multiple…
Pharmacology Consult

Immunotherapy effective for many patients ineligible for registration trials, but caution necessary

HemOnc Today, August 25, 2019
Jai N. Patel, PharmD, BCOP
One of the hot topics at this year’s ASCO Annual Meeting was broadening eligibility criteria to increase clinical trial access and enrollment…
Editorial

America’s new cancer: History repeats itself

HemOnc Today, August 25, 2019
Derek Raghavan, MD, PhD
Long after Doll and Bradford Hill convincingly showed that lung cancer is caused by cigarette smoking, the denizens of the tobacco industry…
Editorial

A new love affair — but will you respect me in the morning?

HemOnc Today, July 25, 2019
Derek Raghavan, MD, PhD
We have known for more than 50 years that immunotherapy is active against noninvasive bladder cancer, dating from the paradigm-altering work of…